Home » Stocks » IDEXX Laboratories

IDEXX Laboratories, Inc. (IDXX)

Stock Price: $390.25 USD -1.74 (-0.44%)
Updated Aug 4, 2020 4:00 PM EDT - Market closed
After-hours: $391.00 +0.75 (0.19%) Aug 4, 6:29 PM

Stock Price Chart

Key Info

Market Cap 33.15B
Revenue (ttm) 2.47B
Net Income (ttm) 460.10M
Shares Out 84.93M
EPS (ttm) 5.29
PE Ratio 73.77
Forward PE 81.97
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 4, 2020
Last Price $390.25
Previous Close $391.99
Change ($) -1.74
Change (%) -0.44%
Day's Open 393.77
Day's Range 385.22 - 394.71
Day's Volume 661,208
52-Week Range 168.65 - 407.86

More Stats

Market Cap 33.15B
Enterprise Value 34.13B
Earnings Date (est) Nov 3, 2020
Ex-Dividend Date n/a
Shares Outstanding 84.93M
Float 84.02M
EPS (basic) 5.38
EPS (diluted) 5.29
FCF / Share 4.31
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.36%
FCF Yield 1.11%
Payout Ratio n/a
Shares Short 1.93M
Short Ratio 3.43
Short % of Float 2.13%
Beta 0.80
PE Ratio 73.77
Forward PE 81.97
P/FCF Ratio 90.28
PS Ratio 13.39
PB Ratio 313.74
Revenue 2.47B
Operating Income 593.01M
Net Income 460.10M
Free Cash Flow 367.15M
Net Cash -984.46M
Net Cash / Share -11.59
Gross Margin 55.18%
Operating Margin 23.96%
Profit Margin 18.60%
FCF Margin 14.84%
ROA 20.57%
ROE 206.87%
ROIC 31.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 5
Overweight 0
Hold 2
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

(-10.93% downside)
Current: $390.25
Target: 347.60
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth8.75%12.4%10.91%10.83%7.81%7.9%6.47%6.13%10.45%-
Gross Profit1,3661,2421,097975890816756699647579
Operating Income553491413350300260267263236204
Net Income428377263222192182188178162141
Shares Outstanding86.1286.8687.7789.7392.60100106110114115
Earnings Per Share4.894.262.942.442.051.791.741.591.391.19
EPS Growth14.79%44.9%20.49%19.02%14.53%2.87%9.78%14.03%17.3%-
Operating Cash Flow459400373339222236246222218179
Capital Expenditures-155-116-74.38-64.79-82.92-60.70-78.64-58.47-50.45-39.19
Free Cash Flow304284299274139175167164167140
Cash & Equivalents90.33124472392343323279224184157
Total Debt1,0551,0001,2611,2041,170899428215246133
Net Cash / Debt-965-876-789-812-828-576-1499.49-62.5223.64
Book Value177-9.51-54.11-108-84.13118518636540574
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name IDEXX Laboratories, Inc.
Country United States
Employees 9,000
CEO Jonathan J. Mazelsky

Stock Information

Ticker Symbol IDXX
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: IDXX
IPO Date June 21, 1991


IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.